Panbela Therapeutics Inc (PBLA) Stock Price & News

All values in USD	2023-ж. дек.	2024-ж. мар.	2024-ж. июн.	2024-ж. сен.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	6,05 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	-	1,11 млн
Operating expense	-	-	-	7,16 млн
Total operating expenses	-	-	-	7,16 млн
Operating income	-	-	-	-7,16 млн
Other non operating income	-	-	-	-
EBT including unusual items	-	-	-	-7,17 млн
EBT excluding unusual items	-	-	-	-7,17 млн
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-	-	-	-7,17 млн
Net profit margin	-	-	-	-
Earnings per share	-65,90	-2,28	-1,47	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-442,00 миң
Net interest expenses	-	-	-	-442,00 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance